Table 1.
Baseline characteristics of patients.
| Variable† | n = 95 |
|---|---|
| Age, year | 66.1 ± 9.8 |
| Sex, male | 48 (50.5) |
| BMI, kg/m2 | 24.46 ± 3.17 |
| Baseline liver status | |
| Chronic liver disease | 57 (60.0) |
| Compensated LC | 38 (40.0) |
| Previous pegIFN/RBV | 30 (31.6) |
| Liver stiffness, kPa | 18.26 ± 12.63 |
| Fibrosis stage | |
| F2 | 10 (11.0) |
| F3 | 29 (31.9) |
| F4 | 52 (57.1) |
| AST | 60.0 ± 23.3 |
| ALT | 41.7 ± 22.8 |
| Total bilirubin, μMol/L | 1.00 ± 0.59 |
| Platelet, /μL | 140.4 ± 52.2 |
| PT, INR | 1.09 ± 0.19 |
| Albumin, g/dL | 4.01 ± 0.46 |
†Continuous variables are described as mean ± standard deviation. Nominal variables are described as number (percentage).
BMI, body mass index; LC, liver cirrhosis; IFN, interferon; AST, aspartate transaminase; ALT, alanine transaminase; PT, prothrombin time; INR, internationalized ratio; SVR, sustained viral response.